Compare Arqit Quantum Inc (ARQQ) vs Neurocrine Biosciences Inc (NBIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Arqit Quantum Inc vs Neurocrine Biosciences Inc — how do they compare? Arqit Quantum Inc trades at $23.77 (market cap $424.79M), while Neurocrine Biosciences Inc trades at $157.5 (market cap $16.46B). The key difference: Neurocrine Biosciences Inc is far larger — about 38.7× Arqit Quantum Inc's market cap, and Neurocrine Biosciences Inc is trading nearer its 52-week high, Arqit Quantum Inc nearer its low. Which is the better fit depends on your goals.
| ARQQ | NBIX | |
|---|---|---|
Market Cap | $424.79M | $16.46B |
Sector | Technology | Health |
52-Week High | $58.27 | $185.50 |
52-Week Low | $11.78 | $123.10 |
Enterprise Value | $398.10M | $16.48B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Arqit Quantum Inc
Arqit Quantum provides advanced cybersecurity software that uses symmetric key agreement technology. Its solutions protect networked devices and data against current and future cyber threats, including quantum attacks.
Read more on ARQQ →About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →
